Most people who could benefit from pre-exposure prophylaxis are not accessing it, the U.S. Centers for Disease Control and Prevention revealed at this year's Conference on Retroviruses and Opportunistic Infections.
Rob Newells, executive director of the AIDS Project of the East Bay, gives his personal (U.S.-centered, black MSM-focused) highlights from CROI 2018.
Gina Brown, M.D., shares her reflections on some of the many research findings about HIV prevention, care, and treatment for women and girls presented at CROI 2018.
Three video interviews with federal HIV leaders who shared perspectives about the science coming out of the conference and its implications for HIV prevention, care, and treatment.
Nearly 90 percent of participants in an open-label study of a vaginal ring infused with a drug to prevent HIV are using the monthly ring at least some of the time, according to data presented at CROI 2018.
Several PrEP studies presented at IDWeek focused on the need for better education among clinicians and medical students regarding not only how PrEP works and whom it can benefit but also that it even exists as an HIV prevention option.
With a Cupcake and a Condom (and a Lot More), an Educator Promotes HIV Prevention Among Young Black Women
Shawna Edgerson, M.P.H., a prevention specialist with KC CARE (Care Access Research Education) in Kansas City, Missouri, has a passion for making sure that young black women get the message about safer sex with men. And she does it with a sweet treat...
With black women at far greater risk for HIV than women of any other race or ethnicity, health organizations should think more creatively about how to bring them HIV and PrEP information.
Federal Leaders Work Together to Get the Word Out About Research Showing Viral Suppression Prevents HIV Transmission
Even though there were few sessions at the U.S. Conference on AIDS dedicated specifically to treatment as prevention, there were discussions going on everywhere about it.
Many trans women living with HIV may contract the virus because they or their sexual partners are intravenous drug users (IDU), finds a new study.